Metagenomi Therapeutics, Inc. (MGX)
1.73
+0.10
(+6.13%)
USD |
NASDAQ |
Jan 22, 10:32
Metagenomi Therapeutics Total Liabilities (Quarterly): 69.49M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.415B |
| AnaptysBio, Inc. | 382.51M |
| Ovid Therapeutics, Inc. | 19.15M |
| Nutriband, Inc. | 0.8702M |
| Cogent Biosciences, Inc. | 123.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 247.94M |
| Shareholders Equity (Quarterly) | 178.45M |
| Debt to Equity Ratio | 0.2335 |
| Current Ratio | 6.416 |
| Net Debt Paydown Yield | 1.41% |